Evidence map›Paper›PMID 34082845›Full record

ArticleCardiology in the young2021

Characterisation of neurodevelopmental and psychological outcomes in CHD: a research agenda and recommendations from the cardiac neurodevelopmental outcome collaborative.

Jacqueline H Sanz, Julia Anixt, Laurel Bear, Amy Basken, John Beca, Bradley S Marino, Kathleen A Mussatto, Wendy N Nembhard, Anjali Sadhwani, Renee Sananes and 5 more

Abstract read
In one paragraph

Article in Cardiology in the young, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Atypical Development of Functional Brain Networks in Neonates with Congenital Heart Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jacqueline H SanzDivision of Neuropsychology, Children's National Hospital, Departments of Psychiatry and Behavioral Sciences & Pediatrics, George Washington University School of Medicine, Washington, DC, USA.
Julia AnixtDivision of Developmental and Behavioral Pediatrics, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Laurel BearDepartment of Pediatrics, Medical College of Wisconsin, Herma Heart Institute, Children's Wisconsin, Milwaukee, Wisconsin, USA.
Amy BaskenConquering CHD, Madison, Wisconsin, USA.
John BecaDepartment of Intensive Care, Starship Children's Health, Auckland, New Zealand.
Bradley S MarinoDepartment of Pediatric Cardiology, Cleveland Clinic Children's Hospital, Cleveland, Ohio, USA.
Kathleen A MussattoSchool of Nursing, Milwaukee School of Engineering, Milwaukee, Wisconsin, USA.
Wendy N NembhardDepartment of Epidemiology and the Arkansas Birth Defects Center for Research and Prevention, Fay W Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Anjali SadhwaniDepartment of Psychiatry, Boston Children's Hospital & Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Renee SananesDivision of Cardiology, Department of Psychology, The Hospital for Sick Children, Department of Pediatrics, The University of Toronto, Toronto, Canada.ORCID https://orcid.org/0000-0002-6917-379X
Lara S ShekerdemianDepartment of Pediatrics, Section of Critical Care, Baylor College of Medicine, Houston, TX, USA.
Erica SoodNemours Cardiac Center, Alfred I. duPont Hospital for Children, Wilmington, DE & Department of Pediatrics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0001-8817-4213
Karen UzarkDepartment of Pediatrics, Section of Pediatric Cardiology, University of Michigan C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.
Elizabeth WillenDivision of Developmental and Behavioral Sciences and the Ward Family Heart Center, Children's Mercy, Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.
Dawn IlardiDepartment of Neuropsychology, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, USA.ORCID https://orcid.org/0000-0002-5488-9015

Funding

Optimizing Neurodevelopmental Outcomes for Survivors with Congenital Heart Disease: Knowledge Gaps, Research Challenges and OpportunitiesR13HL142298 · NHLBI · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI MARINO, BRADLEY SCOTT · 2018 to 2018
$24k
NHLBI NIH HHS R13 HL142298
6 · The paper itself

Abstract

The Neurodevelopmental and Psychological Outcomes Working Group of the Cardiac Neurodevelopmental Outcome Collaborative was formed in 2018 through support from an R13 grant from the National Heart, Lung, and Blood Institute with the goals of identifying knowledge gaps regarding the neurodevelopmental and psychological outcomes of individuals with CHD and investigations needed to advance science, policy, clinical care, and patient/family outcomes. Accurate characterisation of neurodevelopmental and psychological outcomes in children with CHD will drive improvements in patient and family outcomes through targeted intervention. Decades of research have produced a generalised perspective about neurodevelopmental and psychological outcomes in this heterogeneous population. Future investigations need to shift towards improving methods, measurement, and analyses of outcomes to better inform early identification, prevention, and intervention. Improved definition of underlying developmental, neuropsychological, and social-emotional constructs is needed, with an emphasis on symptom networks and dimensions. Identification of clinically meaningful outcomes that are most important to key stakeholders, including patients, families, schools and providers, is essential, specifically how and which neurodevelopmental differences across the developmental trajectory impact stakeholders. A better understanding of the discontinuity and patterns of neurodevelopment across the lifespan is critical as well, with some areas being more impactful at some ages than others. Finally, the field needs to account for the impact of race/ethnicity, socio-economic status, cultural and linguistic diversity on our measurement, interpretation of data, and approach to intervention and how to improve generalisability to the larger worldwide population of patients and families living with CHD.

Indexed as

EmotionsSchoolsChildHumansCHDNeurodevelopmental outcomesparents and stakeholderspsychological outcomes

Identifiers

PMID34082845
PMCPMC8429101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.